References
1. Addressing Health Inequalities in the European Union. 2020.
2. Geller SE, Koch AR, Roesch P, Filut A, Hallgren E, Carnes M. The More
Things Change, the More They Stay the Same: A Study to Evaluate
Compliance With Inclusion and Assessment of Women and Minorities in
Randomized Controlled Trials. Acad Med. 2018;93(4):630-5. doi:
10.1097/ACM.0000000000002027.
3. Duma N, Vera Aguilera J, Paludo J, Haddox CL, Gonzalez Velez M, Wang
Y, et al. Representation of Minorities and Women in Oncology Clinical
Trials: Review of the Past 14 Years. J Oncol Pract. 2018;14(1):e1-e10.
doi: 10.1200/JOP.2017.025288.
4. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical
trials: race-, sex-, and age-based disparities. JAMA.
2004;291(22):2720-6. doi: 10.1001/jama.291.22.2720.
5. Zavala VA, Bracci PM, Carethers JM, Carvajal-Carmona L, Coggins NB,
Cruz-Correa MR, et al. Cancer health disparities in racial/ethnic
minorities in the United States. Br J Cancer. 2021;124(2):315-32. doi:
10.1038/s41416-020-01038-6.
6. de Groot P, Munden RF. Lung cancer epidemiology, risk factors, and
prevention. Radiol Clin North Am. 2012;50(5):863-76. doi:
10.1016/j.rcl.2012.06.006.
7. Torre LA, Siegel RL, Jemal A. Lung Cancer Statistics. Adv Exp Med
Biol. 2016;893:1-19. doi: 10.1007/978-3-319-24223-1_1.
8. Subramanian J, Madadi AR, Dandona M, Williams K, Morgensztern D,
Govindan R. Review of ongoing clinical trials in non-small cell lung
cancer: a status report for 2009 from the ClinicalTrials.gov website. J
Thorac Oncol. 2010;5(8):1116-9. doi: 10.1097/JTO.0b013e3181e76159.
9. Jung KJ, Jeon C, Jee SH. The effect of smoking on lung cancer: ethnic
differences and the smoking paradox. Epidemiol Health. 2016;38:e2016060.
doi: 10.4178/epih.e2016060.
10. Meza R, Meernik C, Jeon J, Cote ML. Lung cancer incidence trends by
gender, race and histology in the United States, 1973-2010. PLoS One.
2015;10(3):e0121323. doi: 10.1371/journal.pone.0121323.
11. Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau
D, et al. SciPy 1.0: fundamental algorithms for scientific computing in
Python. Nat Methods. 2020;17(3):261-72. doi: 10.1038/s41592-019-0686-2.
12. Hunter JD. Matplotlib: A 2D graphics environment. Computing in
science & engineering. 2007;9(03):90-5.
13. Cancer Statistics Center.
http://cancerstatisticscenter.cancer.org Accessed.
14. Khan SU, Khan MZ, Raghu Subramanian C, Riaz H, Khan MU, Lone AN, et
al. Participation of Women and Older Participants in Randomized Clinical
Trials of Lipid-Lowering Therapies: A Systematic Review. JAMA Netw Open.
2020;3(5):e205202. doi: 10.1001/jamanetworkopen.2020.5202.
15. Jin X, Chandramouli C, Allocco B, Gong E, Lam CSP, Yan LL. Women’s
Participation in Cardiovascular Clinical Trials From 2010 to 2017.
Circulation. 2020;141(7):540-8. doi: 10.1161/CIRCULATIONAHA.119.043594.
16. Brahan D, Bauchner H. Changes in reporting of race/ethnicity,
socioeconomic status, gender, and age over 10 years. Pediatrics.
2005;115(2):e163-6. doi: 10.1542/peds.2004-1437.
17. Geller SE, Koch A, Pellettieri B, Carnes M. Inclusion, analysis, and
reporting of sex and race/ethnicity in clinical trials: have we made
progress? J Womens Health (Larchmt). 2011;20(3):315-20. doi:
10.1089/jwh.2010.2469.
18. Loree JM, Anand S, Dasari A, Unger JM, Gothwal A, Ellis LM, et al.
Disparity of Race Reporting and Representation in Clinical Trials
Leading to Cancer Drug Approvals From 2008 to 2018. JAMA Oncol.
2019;5(10):e191870. doi: 10.1001/jamaoncol.2019.1870.
19. Jayakrishnan T, Aulakh S, Baksh M, Nguyen K, Ailawadhi M, Samreen A,
et al. Landmark Cancer Clinical Trials and Real-World Patient
Populations: Examining Race and Age Reporting. Cancers (Basel).
2021;13(22). doi: 10.3390/cancers13225770.